Related references
Note: Only part of the references are listed.The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells
Chang-Jiang Hu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma
Fan-Di Meng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
Wen-Tai Chiu et al.
ONCOTARGET (2015)
Down-regulation of MicroRNA-494 via Loss of SMAD4 Increases FOXM1 and β-Catenin Signaling in Pancreatic Ductal Adenocarcinoma Cells
Lei Li et al.
GASTROENTEROLOGY (2014)
USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma
Zhen Ning et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
Ning Wen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data
Martha M. Kirstein et al.
ONCOLOGIST (2014)
Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer
Fei-Fei Kong et al.
ONCOLOGY REPORTS (2014)
Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
Fung Zhao et al.
PLOS ONE (2014)
Up-Regulation of FOXM1 by E6 Oncoprotein through the MZF1/NKX2-1 Axis Is Required for Human Papillomavirus-Associated Tumorigenesis
Po-Ming Chen et al.
NEOPLASIA (2014)
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
Anna Bergamaschi et al.
BREAST CANCER RESEARCH (2014)
Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
Kaoru Okada et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival
R. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
The Critical Role of Dysregulated FOXM1-PLAUR Signaling in Human Colon Cancer Progression and Metastasis
Dawei Li et al.
CLINICAL CANCER RESEARCH (2013)
Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score
Sung Gwe Ahn et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
Xiaoxiao Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
Yu Wang et al.
LUNG CANCER (2013)
Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma
Xiao-Rong Wu et al.
MEDICAL ONCOLOGY (2013)
FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis
Nuo Xu et al.
PLOS ONE (2013)
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells
Deborah A. Sanders et al.
GENOME BIOLOGY (2013)
FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer
Xiao-Yuan Chu et al.
ACTA HISTOCHEMICA (2012)
Involvement of FoxM1 in Non-Small Cell Lung Cancer Recurrence
Nuo Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51
Nu Zhang et al.
CLINICAL CANCER RESEARCH (2012)
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells
Jipeng Li et al.
FEBS LETTERS (2012)
FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer
Shan-yang He et al.
GYNECOLOGIC ONCOLOGY (2012)
Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma
Limin Xia et al.
JOURNAL OF HEPATOLOGY (2012)
Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma
Yi-Jun Xue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Overexpression of FOXM1 Is Associated With Poor Prognosis and Clinicopathologic Stage of Pancreatic Ductal Adenocarcinoma
Jin-Tang Xia et al.
PANCREAS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria
Hongcheng Sun et al.
CANCER LETTERS (2011)
FoxM1: A Master Regulator of Tumor Metastasis
Pradip Raychaudhuri et al.
CANCER RESEARCH (2011)
Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients
Markus Priller et al.
CLINICAL CANCER RESEARCH (2011)
Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor
Jinsheng Yu et al.
CLINICAL CANCER RESEARCH (2011)
Overexpression of Forkhead Box M1 transcription factor and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis
Li-Zhu Jiang et al.
HUMAN PATHOLOGY (2011)
被撤回的出版物: Over-Expression of FoxM1 Leads to Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype in Pancreatic Cancer Cells (Retracted article. See vol. 117, pg. 1963, 2016)
Bin Bao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma
Hong-Cheng Sun et al.
ONCOLOGY REPORTS (2011)
被撤回的出版物: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors (Retracted article. See vol. 158, pg. 607, 2016)
Aamir Ahmad et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Forkhead box M1 transcription factor: A novel target for cancer therapy
Zhiwei Wang et al.
CANCER TREATMENT REVIEWS (2010)
Targeting the TGF-beta 1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy
Mitchell S. Anscher
ONCOLOGIST (2010)
Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
Qiang Li et al.
CANCER RESEARCH (2009)
Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance
Doo Kyung Yang et al.
HUMAN PATHOLOGY (2009)
FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip1
Jiping Zeng et al.
JOURNAL OF PATHOLOGY (2009)
FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation
Emilios Gemenetzidis et al.
PLOS ONE (2009)
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
Nuran Bektas et al.
BMC CANCER (2008)
FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells
Yujian Zhang et al.
CANCER RESEARCH (2008)
FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression
Samuel K. M. Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Anaphase-promoting complex/cyclosome-Cdh1-mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase
Hyun Jung Park et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression
Vladimir Petrovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
FOXM1, a typical proliferation-associated transcription factor
Inken Wierstra et al.
BIOLOGICAL CHEMISTRY (2007)
Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells
B. Dai et al.
ONCOGENE (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
The Forkhead Box M1 transcription factor contributes to the development and growth of mouse colorectal cancer
Yuichi Yoshida et al.
GASTROENTEROLOGY (2007)
Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes
Yongjun Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
FoxM1: At the crossroads of ageing and cancer
Jamila Laoukili et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2
Inken Wierstra et al.
FEBS JOURNAL (2006)
Regulation of late G1/S phase transition and APCCdh1 by reactive oxygen species
Courtney G. Havens et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells
MG Liu et al.
CANCER RESEARCH (2006)
The forkhead box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer
IM Kim et al.
CANCER RESEARCH (2006)
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c
RYM Ma et al.
JOURNAL OF CELL SCIENCE (2005)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
